Geode Capital Management
CGTX icon

Geode Capital Management’s Cognition Therapeutics CGTX Stock Holding History

Geode Capital Management’s Portfolio CGTX Stock Details CGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$876K Buy
911,526
+1,520
+0.2% +$1.53K ﹤0.01% 3367
2026
Q2 		$1.05M Sell
910,006
-10,202
-1% -$12.1K ﹤0.01% 3348
2026
Q1 		$699K Buy
920,208
+46,254
+5% +$53.8K ﹤0.01% 3470
2025
Q4 		$1.18M Buy
873,954
+161,227
+23% +$262K ﹤0.01% 3324
2025
Q3 		$963K Buy
712,727
+344,007
+93% +$469K ﹤0.01% 3389
2025
Q2 		$114K Sell
368,720
-241
-0.1% -$81 ﹤0.01% 4029
2025
Q1 		$155K Buy
368,961
+16,613
+5% +$9.8K ﹤0.01% 3916
2024
Q4 		$247K Buy
352,348
+28,705
+9% +$14.2K ﹤0.01% 3831
2024
Q3 		$152K Buy
323,643
+78,876
+32% +$81.3K ﹤0.01% 3986
2024
Q2 		$406K Buy
244,767
+59,571
+32% +$119K ﹤0.01% 3646
2024
Q1 		$337K Buy
185,196
+10,398
+6% +$21.5K ﹤0.01% 3758
2023
Q4 		$323K Hold
174,798
– – ﹤0.01% 3769
2023
Q3 		$252K Sell
174,798
-1,700
-1% -$2.66K ﹤0.01% 3887
2023
Q2 		$323K Buy
176,498
+53,900
+44% +$114K ﹤0.01% 3825
2023
Q1 		$243K Hold
122,598
– – ﹤0.01% 3948
2022
Q4 		$257K Buy
122,598
+42,189
+52% +$85.2K ﹤0.01% 3958
2022
Q3 		$152K Buy
80,409
+65,238
+430% +$136K ﹤0.01% 4356
2022
Q2 		$32K Buy
15,171
+1,445
+11% +$3.73K ﹤0.01% 4859
2022
Q1 		$37K Buy
+13,726
New +$52.9K ﹤0.01% 4861

Other funds holding CGTX

BIOS Capital Management
BIOS Capital Management Fort Worth, Texas $34.2M AUM 13.29% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.38B AUM 21% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Hilton Capital Management
Hilton Capital Management Garden City, New York $1.47B AUM 11.48% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
CM
CM Management Gulf Breeze, Florida $149M AUM 35.54% 1-Year Est. Return
Sigma Planning Corp
Sigma Planning Corp Ann Arbor, Michigan $3.88B AUM 23.38% 1-Year Est. Return

Geode Capital Management's CGTX Position: Q3 2026 in Review

Geode Capital Management increased its Cognition Therapeutics (CGTX) stake by 0.17% in Q3 2026, buying an estimated $1.53K and bringing the position to 911,526 shares worth $876K. The position accounts for ﹤0.01% of the portfolio, ranked #3367.

Geode Capital Management first reported a position in CGTX in Q1 2022 and has held it in 19 quarters since. The position peaked at $1.18M in Q4 2025. 60 funds tracked by Wall St. Rank hold CGTX as of Q3 2026.

  • Geode Capital Management held 911,526 shares of Cognition Therapeutics worth $876K as of Q3 2026.
  • Geode Capital Management bought 1,520 Cognition Therapeutics shares in Q3 2026, an estimated $1.53K.
  • Cognition Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #3367 holding.
  • Geode Capital Management first reported a position in Cognition Therapeutics in Q1 2022 and has held it in 19 quarters since.
  • Geode Capital Management's Cognition Therapeutics position peaked at $1.18M in Q4 2025.
  • 60 funds tracked by Wall St. Rank held Cognition Therapeutics as of Q3 2026.

Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.